Pulling SEC filings + quote and writing the call…
LXRX
LEXICON PHARMACEUTICALS, INC.
Next earnings Aug 4, 2026 · consensus $-0.05 EPS, $4.08M rev
Last earnings +5.0% on 2026-05-07
$2.10
▲ +4.48%$2.01▲ +200.00%
over 1Y
L $0.67EODHDH $2.44
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.5%
1W+6.3%
1M-5.6%
3M+24.1%
YTD+76.3%
1Y+200.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Revenue grew 60.2% YoY; but unprofitable (net margin -101.1%).
LEXICON PHARMACEUTICALS, INC. shows $49.8M in FY2025 revenue (+60.2% YoY), a -101.1% net margin, and -46.8% ROE.
Sources: SEC EDGAR (CIK 0001062822, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 7:15:17 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.